Call for Abstract

14th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics, will be organized around the theme “A step towards translating novel therapies to control Diabetes”

Diabetes Medicare-2016 is comprised of 8 tracks and 79 sessions designed to offer comprehensive sessions that address current issues in Diabetes Medicare-2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Diabetes is one of the most significant global health concerns of modern times. The causes of type 2 diabetes are multi-factorial and include both genetic and environmental elements that affect beta-cell function and tissue (muscle, liver, adipose tissue, and pancreas) insulin sensitivity. A number of factors have been suggested as possibly linking insulin resistance and beta-cell dysfunction in the pathogenesis of Type 2 Diabetes. A majority of individuals suffering from type 2 diabetes are obese, with central visceral adiposity. According to the International Diabetes Federation, diabetes statistics says that there are more than 317 million people have been diagnosed with diabetes, and an additional 187 million are living undiagnosed. The global revenue earned from drugs sales to treat Type 2 Diabetes was approximately $36.89 billion in 2012 that is rapidly increasing in incidence and prevalence across the globe predicated to elevate this figure to approximately $68.42 billion by 2017. Patients with this disease cannot use glucose properly for their body needs. Latest research on Diabetes has led to the better living of the diabetic patients. In addition to this, self-monitoring of Blood glucose levels, lifestyle modifications and health eating habits are crucial in combating the critical manifestations of this disease which may require proper diabetic nursing. This may also include considerable amount of time educating patients and families on proper dietary, exercise and lifestyle habits to keep symptoms under control.

  • Track 1-1New insights into beta cell signaling pathways
  • Track 1-2Beta cell and Aging
  • Track 1-3Role of non-beta cells in glucose homeostasis
  • Track 1-4Role of DNA methylation in insulin secretion
  • Track 1-5Genetic defects in insulin action
  • Track 1-6Diabetes in specific ethnic groups
  • Track 1-7Genetics of metabolic syndrome: Challenges and relation with Diabetes Mellitus
  • Track 1-8Beta cell regeneration & encapsulation research
  • Track 1-9Genetic Defects of Beta Cell Function

Novel therapeutic targets available for diabetes includes Incretin based therapies, oral therapeutic agents like secretagogues, beta cell regeneration & proliferation and stem cell therapies.  Embryonic stem cell and fetal precursor cell transplantation therapies are the major stem cell therapies available for Diabetes. Apart from the above, various computational approaches in Diabetes management have been introduced recently with latest diabetes clinical trial going on which are playing an important role in identification of genes causing diabetes helping in Early Detection of Diabetes. These processes are also useful in studying the chemical etiologies of Diabetes uncovering various treatment prospects and model construction processes for survival prediction cobating the compliactions of diabetes like Gestational Diabetes, Diabetes Myopathy, Diabetes cardiopathy and more.

  • Track 2-1Non-invasive diagnostic tool and imaging of Diabetes
  • Track 2-2Viral infection and β-cell trageting
  • Track 2-3Current vaccine trails for curing Diabetes
  • Track 2-4Preclinical safety evaluation of stem cell-based therapies for Diabetes
  • Track 2-5Microbiota, Diabetes & Obesity
  • Track 2-6Diabetes Case Reports
  • Track 2-7Gestational Diabetes update
  • Track 2-8Incretin based therapies
  • Track 2-9Angioplasty and Coronary Artery Bypass Grafting (CABG)
  • Track 2-10Novel research and treatment strategies on Diabetes
  • Track 2-11Diabetes clinical trials on animal models
  • Track 2-12Prediabetes, anti-diabetes and metabolic syndrome
  • Track 2-13Clinical diagnosis and laboratory tests
  • Track 2-14Clinical case reports and clinical endocrinology practices

With rising numbers of diagnosed diabetics, pharmaceutical manufacturers have capitalized on the burgeoning market for diabetes therapies. Manufacturers' efforts to develop non-invasive methods of insulin delivery are set to revolutionize the insulin therapy market, while demand for oral medications is on the upswing due to a growing Type 2 diabetic population and introduction of technologically advanced therapies for battling complications associated to Type 2 Diabetes like the most prevalent Diabetes Cardiomyopathy. With human embryonic stem cells as a starting point, the scientists are for the first time able to produce, in the kind of massive quantities needed for cell transplantation and pharmaceutical purposes, human insulin-producing beta cells equivalent in most every way to normally functioning beta cells. This will certainly help people recover the prognosis of the fatal disease like diabetes.

  • Track 3-1Diabetic Neuropathy
  • Track 3-2Diabetic Control during Pregnancy
  • Track 3-3Diabetes and obesity
  • Track 3-4Diabetes and cancer
  • Track 3-5Pediatric Diabetes- Challenges and risk factors
  • Track 3-6Geriatric diabetes
  • Track 3-7Diabetes foot care
  • Track 3-8Alzheimer's Disease: Type three Diabetes
  • Track 3-9Reverse Diabetes
  • Track 3-10Diabetic Angiopathy
  • Track 3-11Diabetic Myelopathy
  • Track 3-12Diabetic Mastopathy
  • Track 3-13Diabetic Retinopathy
  • Track 3-14Diabetic Gastroparesis
  • Track 3-15Diabetic Cardiomyopathy
  • Track 3-16Diabetic Nephropathy
  • Track 3-17Veterinary Diabetes

The global diabetes treatment market is undergoing significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. There has been a drastic increase in the incidents of diabetes worldwide, owing to the rising level of lifestyles and obesity in global population. The diabetes treatment products include injectable diabetes drugs, oral drugs, insulin therapies, insulin pumps, insulin injection devices and blood glucose monitoring systems which eliminates the risk of reverse diabetes. According to the new report the world market for diabetes medications will reach $55.3bn in 2017. The anti-diabetic medicines industry generated $35.6bn in 2012, and its revenues will show strong growth to 2023. Monitoring glucose levels is critical for the management of diabetes and new and improved portable, less costly, easy-to-use, accurate and virtually painless blood glucose monitoring systems are now available to take control of the disease.

  • Track 4-1New drug treatments and devices for diabetes
  • Track 4-2Biomarker discovery for treatment of diabetes
  • Track 4-3Transplantation for Diabetes
  • Track 4-4Blood glucose monitoring: Glucose pumps and sensors
  • Track 4-5Inflammatory markers: Type 1 and Type 2 Diabetes
  • Track 4-6Stem cell cure for Diabetes
  • Track 4-7Non-insulin therapies
  • Track 4-8Mobile prescription therapy

Diabetes Mellitus is a dreadful disease and is found in all parts of the world, becoming a serious threat of mankind health. There are lots of chemical agents available to take control on the disease, but total recovery from diabetes is the question to the treatment. Alternative to these synthetic agents, natural cure by plants provides a potential source curing complications of hypoglycemia and reverse Diabetes are widely used in several traditional systems of medicine to prevent prediabetes. Other alternative therapies such as diabetic supplements, acupuncture, hydrotherapy, and yoga therapies are reported to have less likely side effects of conventional approaches for diabetes.

  • Track 5-1Health supplements for managing Diabetes
  • Track 5-2Updates on herbal therapy
  • Track 5-3Cinnamon therapy for dehydration
  • Track 5-4Acupuncture therapy
  • Track 5-5Chiropractic treatments
  • Track 5-6Lifestyle changes, physical activity & yoga therapy


Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. As the number of patients grows across the globe, there has never been a stronger and more urgent need for novel therapeutic measures in clinical and preclinical evaluation, that arrest the growth of the disease. The diabetes market, consisting mainly of Type 1 and Type 2 diabetes, is large and growing significantly. The global market value for diabetes therapies and diagnostics has reached to $48.5 billion. The largest segment of the market, insulin products, is worth $20.8 billion in the recent times, including administration and diagnostic devices. Monitoring devices and other related equipment, the second-largest market is established with an investment of $13.5 billion in which was proposed for $11.3. The fastest-growing segment of oral diabetic complication of hypoglycemia drugs manufacturing funding is $14.13 in present scenario of diabetes market.

  • Track 6-1Recent advances in diabetic drugs( Januvia, Lantus, Novolog, Humalog, Janument)
  • Track 6-2Artificial and bio-artificial pancreas
  • Track 6-3IPR and socio issues in Diabetes research
  • Track 6-4Antidiabetic medicines or drugs
  • Track 6-5Bariatric surgery and obesity
  • Track 6-6Human insulins and analogues
  • Track 6-7Diabetes steroid and hormone
  • Track 6-8Diabetic diet products- Companies and market analysis

With the growing awareness and information regarding preventive measures for combating fatal disease like diabetes, consumers are opting for proper food along with medicines. One can improve the health in a big way by making small changes to the diet, while still enjoying the favorite foods and taking pleasure from the meals. A diabetes diet is simply a healthy eating plan that is high in nutrients, low in fat, and moderate in calories. Manufacturers are now keen towards Diabetes Nutrition on introducing new low calorie food products with sugar substitutes and less oil, in view of the increasing consumer interest toward healthy eating and help prevent diabetes and its concomitant risk factors.

  • Track 7-1Dietary fats and Diabetes
  • Track 7-2Pre-diabetes Diet
  • Track 7-3Proteins and Diabetes
  • Track 7-4Carbohydrate counting and Glycemic Index
  • Track 7-5Gluten-free diet for diabetic
  • Track 7-6Diabetic meal plan
  • Track 7-7Micronutrients and diabetes
  • Track 7-8Primary care for Diabetes
  • Track 7-9Diabetic counseling and prevention methodologies

Current Research in diabetes is focusing on developing Implantable insulin pumps which introduced Insulin pump therapy, disruption of fat metabolism, invasive and non-invasive glucose sensors, Artificial pancreas, New insulin delivery systems like inhaled, transdermal and implantable devices, Insulin Pens, Bariatric surgery and Conventional therapeutic approaches. Traditional approaches like Acupuncture and herbal medications are playing vital role in treatment of Diabetes and its related risk factors covering majorly obesity and Diabetes.

  • Track 8-1New therapeutic mechanisms for Diabetes
  • Track 8-2New Insulin delivery systems: Inhaled, transdermal & implanted devices
  • Track 8-3Computational approach to chemical etiologies of Diabetes
  • Track 8-4Glucose sensors (invasive and non-invasive)
  • Track 8-5Bariatric surgery versus conventional therapy
  • Track 8-6Challenges in the adoption of technology into Diabetes care
  • Track 8-7Advanced medical technologies used in hospitals
  • Track 8-8Biostator: closed loop system